PLCG2 and cancer: Interestingly, further GSEA analysis showed that the "PI3K-Akt signaling pathway", "T cell receptor signaling pathway", "mTOR signaling pathway" and "PD-L1 expression and PD-1 checkpoint pathway in cancer" were significantly activated in PLCG2 high-expression group (Figure 7C).